ACRO Biomedical Valuation
| ACBM Stock | USD 0 0.00 0.00% |
ACRO Biomedical seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of ACRO Biomedical from examining the entity fundamentals such as Price To Sales of 267.90 X, current valuation of 240.18 M, and Operating Margin of (17.61) % as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ACRO Biomedical's price fluctuation is very steady at this time. Calculation of the real value of ACRO Biomedical is based on 3 months time horizon. Increasing ACRO Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ACRO pink sheet is determined by what a typical buyer is willing to pay for full or partial control of ACRO Biomedical Co. Since ACRO Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ACRO Pink Sheet. However, ACRO Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.001 | Real 8.4E-4 | Hype 0.001 |
The intrinsic value of ACRO Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ACRO Biomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ACRO Biomedical Co helps investors to forecast how ACRO pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ACRO Biomedical more accurately as focusing exclusively on ACRO Biomedical's fundamentals will not take into account other important factors: ACRO Biomedical Total Value Analysis
ACRO Biomedical Co is presently forecasted to have valuation of 240.18 M with market capitalization of 209.55 M, debt of 59.44 K, and cash on hands of 12.11 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ACRO Biomedical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
240.18 M | 209.55 M | 59.44 K | 12.11 K |
ACRO Biomedical Investor Information
About 50.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.2. ACRO Biomedical had not issued any dividends in recent years. The entity had 3:1 split on the 22nd of May 2017. ACRO Biomedical Co is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.ACRO Biomedical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ACRO Biomedical has an asset utilization ratio of 157.34 percent. This suggests that the Company is making $1.57 for each dollar of assets. An increasing asset utilization means that ACRO Biomedical Co is more efficient with each dollar of assets it utilizes for everyday operations.ACRO Biomedical Ownership Allocation
ACRO Biomedical holds a total of 60.04 Million outstanding shares. ACRO Biomedical retains considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.ACRO Biomedical Profitability Analysis
The company reported the previous year's revenue of 1.2 M. Net Income was 7.7 M with profit before overhead, payroll, taxes, and interest of 259.5 K.About ACRO Biomedical Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of ACRO Biomedical Co. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ACRO Biomedical based exclusively on its fundamental and basic technical indicators. By analyzing ACRO Biomedical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of ACRO Biomedical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of ACRO Biomedical. We calculate exposure to ACRO Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ACRO Biomedical's related companies.Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana. Acro Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct ACRO Biomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ACRO Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ACRO Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ACRO Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ACRO Biomedical's revenue streams: Identify ACRO Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ACRO Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ACRO Biomedical's growth potential: Evaluate ACRO Biomedical's management, business model, and growth potential.
- Determine ACRO Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ACRO Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
ACRO Biomedical Growth Indicators
Investing in growth stocks can be very risky. If the company such as ACRO Biomedical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 47.8 M | |
| Retained Earnings | -7.9 M | |
| Retained Earnings Total Equity | -7.9 M |
Other Information on Investing in ACRO Pink Sheet
ACRO Biomedical financial ratios help investors to determine whether ACRO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACRO with respect to the benefits of owning ACRO Biomedical security.